South Lyon, MI, United States of America

Scott D Larsen

This inventor holds 25 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 14 EPO patents, primarily in Pharmaceutical Inhibitors. Top assignees: University of Michigan, Metabolic Solutions Development Company, LLC, Michigan State University. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott D Larsen. Retrieved from https://idiyas.com/inventor/scott-d-larsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 7)

% Patents Active = 80.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 14 (Patent Applications = 16)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 33(Granted Patents)

Location History:

Ann Arbor, MI (US) (2016 - 2020)
South Lyon, MI (US) (2012 - 2024)

Company Filing History:

19 out of 3,543

University of Michigan

patents

6 out of 11

Metabolic Solutions Development Company, LLC

patents

2 out of 1,439

Michigan State University

The United States Government as Represented by the Department of Veterans Affairs

patents

6. 1 out of 51

The University of Bath

patents

7. 1 out of 899

University of Missouri

patents

8. 1 out of 603

Wayne State University

patents

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

Areas of Expertise:

Small Molecule Inhibitors

ALDH

Glucosylceramide Synthase

G Protein-Coupled Receptors

MRTF/SRF

Therapeutic Methods

PPAR-Sparing Compounds

Thiazolidinedione Salts

Cancer Stem Cells

Bacterial Infections

Inflammatory Conditions

Arbovirus Inhibitors

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11944626 - Small molecule inhibitors of ALDH and uses thereof (2024-04-02),

2. 11220479 - Glucosylceramide synthase inhibitors and therapeutic methods using the same (2022-01-11),

3. 10851072 - Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of the same (2020-12-01),

4. 10662183 - Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same (2020-05-26),

5. 10590142 - Deuterated amlexanox (2020-03-17),

6. 10329283 - G protein-coupled receptor kinase inhibitors and methods for use of the same (2019-06-25),

7. 10202340 - Glucosylceramide synthase inhibitors and therapeutic methods using the same (2019-02-12),

8. 10023564 - G protein-coupled receptor kinase 2 inhibitors and methods for use of the same (2018-07-17),

9. 9944652 - Deuterated amlexanox (2018-04-17),

10. 9598441 - Therapeutic compounds and methods (2017-03-21),

11. 9562012 - PPAR-sparing compounds for the treatment of metabolic diseases (2017-02-07),

12. 9504688 - Methods and compositions for treating bacterial infection (2016-11-29),

13. 9468632 - Methods and compositions for targeting cancer stem cells (2016-10-18),

14. 9365581 - Deuterated amlexanox (2016-06-14),

15. 9126959 - PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases (2015-09-08),

Title: The Innovative Journey of Scott D Larsen

Introduction: Scott D Larsen, a talented inventor hailing from South Lyon, MI (US), has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Scott D Larsen's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, as well as a unique wearable device aimed at enhancing personal safety and well-being.

Career Highlights: With a career spanning over two decades, Scott D Larsen has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its creativity and practicality.

Collaborations: Throughout his career, Scott D Larsen has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Scott D Larsen's passion for innovation and dedication to pushing the boundaries of technology have solidified his position as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.